Search Results - "López Sanromán, A"

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women by Pedersen, N., Bortoli, A., Duricova, D., D′Inca, R., Panelli, M. R., Gisbert, J. P., Zoli, G., López‐Sanromán, A., Castiglione, F., Riegler, G., Annese, V., Gionchetti, P., Prada, A., Pont, E. D., Timmer, A., Felley, C., Shuhaibar, M., Tsianos, E. V., Dejaco, C., Baert, F. J., Jess, T., Lebech, M., Hommes, D. W., Munkholm, P.

“…Summary Background The impact of pregnancy on the course of IBD is still controversial. Aim To investigate the impact of pregnancy on IBD and to search for…”
Get full text

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial by Barbero-Villares, A, Jiménez-Ridruejo, J Mendoza, Taxonera, C, López-Sanromán, A, Pajares, R, Bermejo, F, Pérez-Calle, JL, Mendoza, JL, Algaba, A, Moreno-Otero, R, Maté, J, Gisbert, JP

“…Abstract Background. Methotrexate is an effective treatment for inflammatory bowel disease (IBD). However, long-term treatments have been associated with the…”
Get full text

Mercaptopurine rescue after azathioprine‐induced liver injury in inflammatory bowel disease by BERMEJO, F., LÓPEZ‐SANROMÁN, A., ALGABA, A., VAN‐DOMSELAAR, M., GISBERT, J. P., GARCÍA‐GARZÓN, S., GARRIDO, E., PIQUERAS, B., DE LA POZA, G., GUERRA, I.

“…Summary Background  Azathioprine (AZA) liver toxicity arises in approximately 3% of inflammatory bowel disease patients and may result in treatment…”
Get full text

Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients by González‐Lama, Y., Bermejo, F., López‐Sanromán, A., García‐Sánchez, V., Esteve, M., Cabriada, J. L., McNicholl, A. G., Pajares, R., Casellas, F., Merino, O., Carpio, D., Vera, M. I., Muñoz, C., Calvo, M., Benito, L. M., Bujanda, L., García‐Fernández, F. J., Ricart, E., Ginard, D., Velasco, M., Carneros, J. A., Manceñido, N., Calvo, M., Algaba, A., Froilan, C., Cara, C., Maté, J., Abreu, L., Gisbert, J. P.

“…Aliment Pharmacol Ther 2011; 34: 544–554 Summary Background  Low thiopurine‐methyl‐transferase (TPMT) activity and high 6‐thioguanine‐nucleotide (6TGN)…”
Get full text

Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection by Boixeda, D., Bermejo, F., Martín‐De‐Argila, C., López‐Sanromán, A., Defarges, V., Hernández‐Ranz, F., Milicua, J. M., García‐Plaza, A.

“…Summary Aim : To study the efficacy of a 7‐day quadruple regimen combining pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for…”
Get full text

Idiopathic acute pancreatitis in patients with inflammatory bowel disease: a multicentric cohort study by García García de Paredes, A., Rodríguez-Escaja, C., Iborra, M., Algaba, A., Cameo, J.I., de la Peña, L., Gomollón, F., Van Domselaar, M., Busta, R., Rodríguez de Santiago, E., Castaño García, A., del Val, A., Bermejo, F., Gutiérrez, A., Guardiola, J., Mesonero, F., Riestra, S., Nos, P., Albillos, A., López-Sanromán, A.

Get full text

Role of TNFRSF1B polymorphisms in the response of Crohn’s disease patients to infliximab by Medrano, L.M, Taxonera, C, Márquez, A, Barreiro-de Acosta, M, Gómez-García, M, González-Artacho, C, Pérez-Calle, J.L, Bermejo, F, Lopez-Sanromán, A, Martín Arranz, M.D, Gisbert, J.P, Mendoza, J.L, Martín, J, Urcelay, E, Núñez, C

“…Abstract Infliximab (IFX) is a valid treatment for Crohn’s disease (CD), but a relevant percentage of patients do not benefit from this therapy. In the…”
Get full text

Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia by MARTINEZ-OLMOS, M.Á., LÓPEZ-SANROMÁN, A., MARTÍN-VAQUERO, P., MOLINA-PÉREZ, E., BÁRCENA, RAFAEL, VICENTE, E., CANDELA, Á., PALLARDO-SÁNCHEZ, L.F.

“…We describe a case of glycogen storage disease type Ib in 32-year old male patient with poor metabolic control in spite of medical and nutritional management…”
Get full text

Review article: how to control and improve adherence to therapy in inflammatory bowel disease by LÓPEZ‐SANROMÁN, A., BERMEJO, F.

“…Summary Any chronic disease is a risk situation for non‐adherence to treatment. This results in suboptimal medication, and poor disease control. Adherence and…”
Get full text

Letter: ciclosporin or infliximab in acute ulcerative colitis ‐ still undecided by Lopez‐Sanroman, A., Gisbert, J. P.

Get full text

Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis by Bermejo, F, López-Sanroman, A, Hinojosa, J, Castro, L, Jurado, C, Gómez-Beldal, A B

“…infliximab is a monoclonal antiTNF-ct antibody that has repeatedly shown to be effective in the management of Crohn's disease. However, data are scarce about…”
Get full text

Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine‐induced pancreatitis by BERMEJO, F., LOPEZ‐SANROMAN, A., TAXONERA, C., GISBERT, J. P., PÉREZ‐CALLE, J. L., VERA, I., MENCHÉN, L., MARTÍN‐ARRANZ, M. D., OPIO, V., CARNEROS, J. A., VAN‐DOMSELAAR, M., MENDOZA, J. L., LUNA, M., LÓPEZ, P., CALVO, M., ALGABA, A.

“…Summary Background  Pancreatitis is a potentially severe condition. Patients with inflammatory bowel disease (IBD) seem to be at increased risk for acute…”
Get full text

Letter: infliximab and adalimumab in the management of Crohn's disease - are they really comparable? by Lopez-Sanroman, A., Gisbert, J. P.

Get full text

Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy by MIQUEL, J, BARCENA, R, BOIXEDA, D, FERNANDEZ, J, LOPEZ SANROMAN, A, MARTIN-DE-ARGILA, C, RAMOSA, F

“…Helicobacter pylori infection in cirrhotic patients has been associated with episodes of hepatic encephalopathy (HE), although conclusive data are still…”
Get full text

Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation by González, M.Garcı́a, Hernandez-Madrid, A, Lopez-Sanromán, A, Candela, A, Nuño, J, Barcena, R

Get full text

P440 Polimedication in patients with inflammatory bowel disease: prevalence and outcomes in a retrospective unicentric series by Mesonero Gismero, F, Fernández, C, Sánchez-Rodríguez, E, García-García de Paredes, A, Albillos, A, López-Sanromán, A

“…Abstract Background Polymedication (PM) can complicate course and management of chronic diseases, and is currently a poorly explored issue in patients with…”
Get full text

Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid‐dependent ulcerative colitis by Lopez‐Sanroman, A., Bermejo, F., Carrera, E., Garcia‐Plaza, A.

“…Summary Background : The efficacy of azathioprine in the management of steroid‐dependent ulcerative colitis is taken for granted. However, study populations…”
Get full text

Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU by Mesonero, F., Zabana, Y., Fernández-Clotet, A., Solá, A., Caballol, B., Leo-Carnerero, E., García, M.J., Bertoletti, F., Bastida, G., Suris, G., Casis, B., Ferreiro-Iglesias, R., Calafat, M., Jiménez, I., Miranda-Bautista, J., Lamuela, L.J., Fajardo, I., Torrealba, L., Nájera, R., Sáiz-Chumillas, R.M., González-Partida, I., Vicuña, M., García-Morales, N., Gutiérrez, A., López-García, A., Benítez, J.M., Rubín de Célix, C., Tejido, C., Brunet, E., Hernandez-Camba, A., Suárez, C., Rodríguez-Lago, I., Piqueras, M., Castaño, A., Ramos, L., Sobrino, A., Rodríguez-Grau, M.C., Elosua, A., Montoro, M., Baltar, R., Huguet, J.M., Hermida, B., Caballero-Mateos, A., Sánchez-Guillén, L., Bouhmidi, A., Pajares, R., Baston-Rey, I., López-Sanromán, A., Albillos, A., Barreiro-de Acosta, M.

“…Inflammatory pouch disorders exhibit a heterogeneous clinical spectrum and therapeutic requirements have not been properly studied. This retrospective,…”
Get full text

Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease by Rodríguez‐Lago, Iago, Castro‐Poceiro, Jesús, Fernández‐Clotet, Agnès, Mesonero, Francisco, López‐Sanromán, Antonio, López‐García, Alicia, Márquez, Lucía, Clos‐Parals, Ariadna, Cañete, Fiorella, Vicuña, Miren, Nantes, Óscar, Merino, Olga, Matallana, Virginia, Gordillo, Jordi, Elorza, Ainara, Vicente, Raquel, Casanova, María José, Ferreiro‐Iglesias, Rocío, Pérez‐Galindo, Pablo, Benítez, José Manuel, Taxonera, Carlos, García, María José, Martín, Eduardo, Aguirre, Urko, Gisbert, Javier P., Rodríguez‐Lago, I., Elorza, A., Castro‐Poceiro, J., Fernández‐Clotet, A., Mesonero, F., López‐Sanromán, A., López‐García, A., Márquez, L., Clos‐Parals, A., Cañete, F., Vicuña, M., Nantes, O., Merino, O., Matallana, V., Gordillo, J., Vicente, R., Casanova, M. J., Gisbert, J. P., Ferreiro‐Iglesias, R., Pérez‐Galindo, P., Manuel Benítez, J., Taxonera, C., García, M. J., Martín, E., Aguirre, U., Calafat, M., Muñoz, F., Miquel‐Cusachs, J. O., Sáinz, E.

“…Summary Background Tacrolimus is a calcineurin inhibitor commonly used for prophylaxis of rejection in renal and liver transplantation. There are limited but…”
Get full text

P830 Motherhood and child care are negatively influenced by ulcerative colitis: patients’ insights from the UC-LIFE survey by Carpio, D, Argüelles-Arias, F, Calvet, X, Cea-Calvo, L, Juliá, B, Romero, C, López-Sanromán, A

“…Abstract Background Surveys to patients complement information from clinical studies. In this work, we describe the insights of patients with regard to the…”
Get full text